Enhanced Epimerization of Glycosylated Amino Acids During Solid-Phase Peptide Synthesis
- 5 March 2012
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 134 (14), 6316-6325
- https://doi.org/10.1021/ja212188r
Abstract
Glycopeptides are extremely useful for basic research and clinical applications, but access to structurally defined glycopeptides is limited by the difficulties in synthesizing this class of compounds. In this study, we demonstrate that many common peptide coupling conditions used to prepare O-linked glycopeptides result in substantial amounts of epimerization at the α position. In fact, epimerization resulted in up to 80% of the non-natural epimer, indicating that it can be the major product in some reactions. Through a series of mechanistic studies, we demonstrate that the enhanced epimerization relative to nonglycosylated amino acids is due to a combination of factors, including a faster rate of epimerization, an energetic preference for the unnatural epimer over the natural epimer, and a slower overall rate of peptide coupling. In addition, we demonstrate that use of 2,4,6-trimethylpyridine (TMP) as the base in peptide couplings produces glycopeptides with high efficiency and low epimerization. The information and improved reaction conditions will facilitate the preparation of glycopeptides as therapeutic compounds and vaccine antigens.This publication has 63 references indexed in Scilit:
- Design of Glycopeptides Used to Investigate Class II MHC Binding and T-Cell Responses Associated with Autoimmune ArthritisPLOS ONE, 2011
- Perfluoroalkylated amphiphilic MUC1 glycopeptideantigens as tools for cancer immunotherapyChemical Communications, 2010
- Mice Producing Less Reactive Oxygen Species Are Relatively Resistant to Collagen Glycopeptide Vaccination against ArthritisThe Journal of Immunology, 2010
- Synthetic carbohydrate-based anticancer vaccines: the Memorial Sloan-Kettering experienceExpert Review of Vaccines, 2009
- Immunotherapy for cancer: synthetic carbohydrate-based vaccinesChemical Communications, 2009
- Probing Molecular Interactions within Class II MHC Aq/Glycopeptide/T-Cell Receptor Complexes Associated with Collagen-Induced ArthritisJournal of Medicinal Chemistry, 2007
- Glycopeptides as versatile tools for glycobiologyGlycobiology, 2006
- Vaccination with Theratope® (STn-KLH) as treatment for breast cancerExpert Review of Vaccines, 2004
- Homogeneous Glycopeptides and Glycoproteins for Biological InvestigationAnnual Review of Biochemistry, 2002
- T and Tn, General Carcinoma AutoantigensScience, 1984